59 related articles for article (PubMed ID: 26608299)
21. Protocol for a Steady-State FRET Assay in Cancer Chemoprevention.
Schaap MC; Guimarães AM; Wilderspin AF; Wells G
Methods Mol Biol; 2016; 1379():165-79. PubMed ID: 26608299
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
23. Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction.
Wells G
Biochem Soc Trans; 2015 Aug; 43(4):674-9. PubMed ID: 26551711
[TBL] [Abstract][Full Text] [Related]
24. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction.
Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y
J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486
[TBL] [Abstract][Full Text] [Related]
25. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
27. The emerging role of the Nrf2-Keap1 signaling pathway in cancer.
Jaramillo MC; Zhang DD
Genes Dev; 2013 Oct; 27(20):2179-91. PubMed ID: 24142871
[TBL] [Abstract][Full Text] [Related]
28. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
Sekhar KR; Rachakonda G; Freeman ML
Toxicol Appl Pharmacol; 2010 Apr; 244(1):21-6. PubMed ID: 19560482
[TBL] [Abstract][Full Text] [Related]
29. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
Hayes JD; McMahon M
Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
[TBL] [Abstract][Full Text] [Related]
30. Targeting NRF2 signaling for cancer chemoprevention.
Kwak MK; Kensler TW
Toxicol Appl Pharmacol; 2010 Apr; 244(1):66-76. PubMed ID: 19732782
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
32. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
Kwak MK; Wakabayashi N; Kensler TW
Mutat Res; 2004 Nov; 555(1-2):133-48. PubMed ID: 15476857
[TBL] [Abstract][Full Text] [Related]
34. Monitoring Keap1-Nrf2 interactions in single live cells.
Baird L; Swift S; Llères D; Dinkova-Kostova AT
Biotechnol Adv; 2014 Nov; 32(6):1133-44. PubMed ID: 24681086
[TBL] [Abstract][Full Text] [Related]
35. The Keap1-Nrf2 system and diabetes mellitus.
Uruno A; Yagishita Y; Yamamoto M
Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
[TBL] [Abstract][Full Text] [Related]
36. Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
Mou Y; Wen S; Li YX; Gao XX; Zhang X; Jiang ZY
Eur J Med Chem; 2020 Sep; 202():112532. PubMed ID: 32668381
[TBL] [Abstract][Full Text] [Related]
37. [When defense becomes dangerous--transcription factor Nrf2 and cancer].
Krysztofiak A; Krajka-Kuźniak V
Postepy Hig Med Dosw (Online); 2015 Jan; 69():140-52. PubMed ID: 25614681
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.
Keum YS
Ann N Y Acad Sci; 2011 Jul; 1229():184-9. PubMed ID: 21793854
[TBL] [Abstract][Full Text] [Related]
39. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism.
Chartoumpekis DV; Wakabayashi N; Kensler TW
Biochem Soc Trans; 2015 Aug; 43(4):639-44. PubMed ID: 26551705
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
